SEC Form 4 · accession 0001461959-17-000004
Q BioMed Inc. · QBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William S Rosenstadt
Officer — General Counsel · Director · 10% Owner
Period of report
Mar 29, 2017
Accepted (ET)
Apr 14, 2017 · 11:36 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001596062
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 29, 2017 | S | 4,400 | $5.29 | D | 980,549 | D | |
| Common Stock | Mar 30, 2017 | S | 5,000 | $7.60 | D | 975,549 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on January 17, 2017 for the sale of up to 92,000 shares of common stock. Such sales were outside of the holder's investment decision.